» Articles » PMID: 23090154

Transcription Factor Networks in Invasion-promoting Breast Carcinoma-associated Fibroblasts

Overview
Publisher Springer
Specialty Oncology
Date 2012 Oct 24
PMID 23090154
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Carcinoma-associated fibroblasts (CAFs) contribute to both tumor growth and cancer progression. In this report, we applied an emerging transcription factor (TF) activity array to fibroblasts to capture the activity of the intracellular signaling network and to define a signature that distinguishes mammary CAFs from normal mammary fibroblasts. Normal fibroblasts that restrained cancer cell invasion developed into an invasion-promoting CAF phenotype through exposure to conditioned medium from MDA-MB-231 breast cancer cells. A myofibroblast-like CAF cell line expressing high levels of smooth muscle actin was compared to normal mammary fibroblasts before and after induction. Comparison of TF activity profiles for all three fibroblast types identified a TF activity signature common to CAFs which included activation of reporters for TFs ELK1, GATA1, retinoic acid receptor (RAR), serum response factor (SRF), and vitamin D receptor (VDR). Additionally, CAFs resembling myofibroblasts, relative to normal fibroblasts, had elevated activation corresponding to NF-kappaB, RUNX2, and YY1, and distinct activity patterns for several differentiation-related TF reporters. Induction of CAFs by exposure of normal fibroblasts to conditioned medium from MDA-MB-231 cells resulted in increased activation of reporters for HIF1, several STAT TFs, and proliferation-related TFs such as AP1. Myofibroblast-like CAFs and induced normal mammary fibroblasts promoted invasion of breast cancer cells by distinct mechanisms, consistent with their distinct patterns of TF activation. The TF activity profiles of CAF subtypes provide an overview of intracellular signaling associated with the induction of a pro-invasive stroma, and provide a mechanistic link between the microenvironmental stimuli and phenotypic response.

Citing Articles

Lactate in breast cancer cells is associated with evasion of hypoxia-induced cell cycle arrest and adverse patient outcome.

Liu Y, Suhail Y, Novin A, Afzal J, Pant A, Kshitiz Hum Cell. 2024; 37(3):768-781.

PMID: 38478356 PMC: 11256967. DOI: 10.1007/s13577-024-01046-1.


Tracing the cis-regulatory changes underlying the endometrial control of placental invasion.

Suhail Y, Maziarz J, Novin A, Dighe A, Afzal J, Wagner G Proc Natl Acad Sci U S A. 2022; 119(6).

PMID: 35110402 PMC: 8832988. DOI: 10.1073/pnas.2111256119.


Evolved Resistance to Placental Invasion Secondarily Confers Increased Survival in Melanoma Patients.

Suhail Y, Afzal J, Kshitiz J Clin Med. 2021; 10(4).

PMID: 33562461 PMC: 7915120. DOI: 10.3390/jcm10040595.


Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment.

Cheng H, Lee J, Wahli W, Tan N Mol Cancer. 2019; 18(1):51.

PMID: 30925918 PMC: 6441226. DOI: 10.1186/s12943-019-0971-9.


Synergistic effect of eribulin and CDK inhibition for the treatment of triple negative breast cancer.

Rao S, Stoehr J, Dokic D, Wan L, Decker J, Konopka K Oncotarget. 2017; 8(48):83925-83939.

PMID: 29137393 PMC: 5663565. DOI: 10.18632/oncotarget.20202.


References
1.
Kojima Y, Acar A, Eaton E, Mellody K, Scheel C, Ben-Porath I . Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci U S A. 2010; 107(46):20009-14. PMC: 2993333. DOI: 10.1073/pnas.1013805107. View

2.
Bellis A, Penalver-Bernabe B, Weiss M, Yarrington M, Barbolina M, Pannier A . Cellular arrays for large-scale analysis of transcription factor activity. Biotechnol Bioeng. 2010; 108(2):395-403. PMC: 3022829. DOI: 10.1002/bit.22916. View

3.
Bauer M, Su G, Casper C, He R, REHRAUER W, Friedl A . Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast. Oncogene. 2010; 29(12):1732-40. PMC: 2845730. DOI: 10.1038/onc.2009.463. View

4.
Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Wirapati P . A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med. 2009; 15(1):68-74. DOI: 10.1038/nm.1908. View

5.
Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R . TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 2003; 31(1):374-8. PMC: 165555. DOI: 10.1093/nar/gkg108. View